Andrew Huberman· PhD
That's certainly recommended if there's a family history of of cancer for broa mutations and a a couple of other ones. But you're right it's the tests are available.
Loading…
The evidence is convergent. Multiple independent sources reach the same conclusion, the underlying mechanism is well-characterized, and even the field's most cautious voices treat it as worth doing.
That's certainly recommended if there's a family history of of cancer for broa mutations and a a couple of other ones. But you're right it's the tests are available.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
is that something i should get
the genetic testing for that now has become very standard and increasingly what we're seeing is that when one member of a family is identified as having a brca1 or brca2 mutation we can help that patient in several ways
Whole-body MRI screening in healthy adults produces more incidentaloma harm than cancer-mortality benefit.
Starting colonoscopy screening at 45 (vs 50) prevents enough early-onset cancers to justify the population cost.
Multi-cancer liquid-biopsy tests like Galleri detect early cancers at a stage that meaningfully improves survival.